117 related articles for article (PubMed ID: 18785268)
1. Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy.
Willemsen R; Chames P; Schooten E; Gratama JW; Debets R
Cytometry A; 2008 Nov; 73(11):1093-9. PubMed ID: 18785268
[TBL] [Abstract][Full Text] [Related]
2. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
4. A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.
Willemsen RA; Debets R; Hart E; Hoogenboom HR; Bolhuis RL; Chames P
Gene Ther; 2001 Nov; 8(21):1601-8. PubMed ID: 11894998
[TBL] [Abstract][Full Text] [Related]
5. Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation.
Denkberg G; Reiter Y
Autoimmun Rev; 2006 Apr; 5(4):252-7. PubMed ID: 16697965
[TBL] [Abstract][Full Text] [Related]
6. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
[TBL] [Abstract][Full Text] [Related]
7. Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy.
Li J; Mookerjee B; Wagner J
J Immunother; 2008 Jan; 31(1):81-8. PubMed ID: 18157015
[TBL] [Abstract][Full Text] [Related]
8. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
[TBL] [Abstract][Full Text] [Related]
9. Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytes.
Lamers CH; Sleijfer S; Willemsen RA; Debets R; Kruit WH; Gratama JW; Stoter G
J Biol Regul Homeost Agents; 2004; 18(2):134-40. PubMed ID: 15471217
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
[TBL] [Abstract][Full Text] [Related]
11. HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy.
Hammer MH; Meyer S; Brestrich G; Moosmann A; Kern F; Tesfa L; Babel N; Mittenzweig A; Rooney CM; Hammerschmidt W; Volk HD; Reinke P
Eur J Immunol; 2005 Jul; 35(7):2250-8. PubMed ID: 15915543
[TBL] [Abstract][Full Text] [Related]
12. Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.
Machlenkin A; Uzana R; Frankenburg S; Eisenberg G; Eisenbach L; Pitcovski J; Gorodetsky R; Nissan A; Peretz T; Lotem M
Cancer Res; 2008 Mar; 68(6):2006-13. PubMed ID: 18339883
[TBL] [Abstract][Full Text] [Related]
13. Identification of T-cell epitopes for cancer immunotherapy.
Kessler JH; Melief CJ
Leukemia; 2007 Sep; 21(9):1859-74. PubMed ID: 17611570
[TBL] [Abstract][Full Text] [Related]
14. Genetic engineering of T cell specificity for immunotherapy of cancer.
Willemsen RA; Debets R; Chames P; Bolhuis RL
Hum Immunol; 2003 Jan; 64(1):56-68. PubMed ID: 12507815
[TBL] [Abstract][Full Text] [Related]
15. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.
Fujisawa Y; Nabekura T; Nakao T; Nakamura Y; Takahashi T; Kawachi Y; Otsuka F; Onodera M
Exp Dermatol; 2009 Apr; 18(4):396-403. PubMed ID: 19054057
[TBL] [Abstract][Full Text] [Related]
16. Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells.
Berry LJ; Moeller M; Darcy PK
Tissue Antigens; 2009 Oct; 74(4):277-89. PubMed ID: 19775368
[TBL] [Abstract][Full Text] [Related]
17. Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.
Pameijer CR; Navanjo A; Meechoovet B; Wagner JR; Aguilar B; Wright CL; Chang WC; Brown CE; Jensen MC
Cancer Gene Ther; 2007 Jan; 14(1):91-7. PubMed ID: 17024231
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
Akiyama Y; Maruyama K; Tai S; Komiyama M; Iizuka A; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
Anticancer Res; 2009 Feb; 29(2):647-55. PubMed ID: 19331215
[TBL] [Abstract][Full Text] [Related]
19. The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum.
Westwood JA; Murray WK; Trivett M; Haynes NM; Solomon B; Mileshkin L; Ball D; Michael M; Burman A; Mayura-Guru P; Trapani JA; Peinert S; Hönemann D; Miles Prince H; Scott AM; Smyth MJ; Darcy PK; Kershaw MH
J Immunother; 2009 Apr; 32(3):292-301. PubMed ID: 19242371
[TBL] [Abstract][Full Text] [Related]
20. [Application of gene therapy in tumor adoptive immunotherapy].
Wang C; Zhao Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):482-6. PubMed ID: 18610648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
